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+ MODELIntroduction
Community-acquired Pseudomonas aeruginosa (P. aerugi-
nosa) infections are rare. Most cases involve patients either
with underlying immunosuppression or structural chronic
lung diseases, such bronchiectasis. The virulence factors
play an important role that may lead to acute lung injury,
bacteremia, sepsis and invasion of tissues. P. aeruginosa
possesses a virulence mechanism known as the type III
secretion system. The type III secretory toxin, ExoU is a
major virulence factor associated with poor clinical
outcome. We report here an atypical case of a community-
acquired invasive infection due to a hypervirulent ExoU-
producing strain, in an immunocompetent patient.Case report
A 49 year-old man was admitted to the intensive care unit
(ICU) of our hospital for septic shock. He had no previous
underlying disease, except being a past smoker; he was not
taking any medication and had no relation with any type of
healthcare resources. Three days before ICU admission, he
returned to France by car from Turkey where he had stayed
by the sea for 1 month. During the trip, he reported diffuse
abdominal and back pain with nausea, vomiting and diar-
rhoea associated with chills. He was referred to the
Emergency department of our hospital. Glasgow Coma
Scale was 15/15, blood pressure 75/50 mmHg, heart rate
100 beats/min, respiratory rate 22/min, room air pulse
oximetry 98% and core temperature 37.1 C. Physical ex-
amination revealed diffuse abdominal pain, mainly in the
right upper quadrant of the abdomen, and subcutaneous
erythematous nodules on the torso, pelvis and legs
(Fig. 1A). Laboratory tests on ICU admission were as fol-
lows: leukocytosis 14  109 cell/L (N 4e10  109/L), poly-
morphonuclear neutrophils (PMNs) 11.8  109 (N
1.5e7 x 109/L), haemoglobin 11.6 g/dL (N 12e18 g/dL),
platelet count 113  109 cells/L (N 150e400  109/L),
serum creatinine 307 mmol/l (N 60e120 mmol/l), serum urea
19.5 mmol/L (N 3e7), lactate 3.2 mmol/l (<2 mmol/l),
prothrombin time 60% (N 70e120%), serum bilirubin
19 mmol/l (N < 17), serum aspartate aminotransferase
544 IU/L (N < 35), serum alanine aminotransferase 299 IU/L
(N < 43), and CRP 476.3 mg/L (N < 5). Chest X-ray and
computed tomography (CT) scan showed a left-upperFigure 1. Multiple necrotizing organ damages due to P. aerugino
Section of lung CT scan showing air-space consolidation with necr
Colour fundus photograph of the left eye with two areas of retinit
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tizing pneumonia (Fig. 1B), while abdominal and pelvic CT
scans were unremarkable.
Fluid expansion and catecholamines were administrated
promptly. Empirical antimicrobial therapy including cefo-
taxime, spiramycin and linezolid was initiated. The patient
rapidly developed acute respiratory failure requiring high-
flow nasal cannula oxygen therapy.
A bronchoalveolar lavage (BAL) was performed on day 1,
revealing neutrophilic alveolitis (200  103/ml, 59% PMNs)
without any microorganism on Gram stain. Skin biopsies
were also performed on day 1 on subcutaneous erythema-
tous nodules. Pathological examination revealed lesions of
neutrophilic panniculitis associated with lesions of vascu-
litis with thrombosis suggestive of ecthyma gangrenosum.
Finally, a wild-type P. aeruginosa yielded on BAL, blood,
and urine cultures on day 2, and all the strains had the same
profile of antimicrobial resistance. Viral and fungal cultures
of BAL were negative. Empirical antibiotics were stopped,
and ceftazidime and ciprofloxacin were initiated on day 3.
A binocular blurring followed by a scotoma of the right
eye occurred on day 1. A brain MRI was performed and
found no abnormalities. The fundus examination revealed
subretinal nodules (Fig. 1C) suggestive of endogenous
endophthalmitis. Two intravitreal injections of ceftazidime
were administered on day 8, resulting in a retinal atrophy
scarring on day 15. A functional disability of the left leg
associated with pain occurred on day 4, suggestive of
cruralgia. There were no signs of spondylodiscitis or dis-
coradicular conflict on spinal MRI. A repeat abdominal and
pelvic CT scan revealed a nodular hypodensity of 12 mm at
the femoral insertion of the left ilio-psoas muscle. Finally, a
(18F)-fluorodeoxyglucose positron emission tomography
was performed and identified several areas of increased
metabolic activity within the lungs, the trochanteric
insertion of the left psoas, the prostate and the subcu-
taneous nodules. A trans-oesophageal echocardiography
ruled out an infectious endocarditis.
The patient gradually improved with a rapid decrease
of oxygen therapy and a complete recovery of renal and
liver functions. It should be noted that cutaneous lesions
co-existed at different stages of development, some of
which had evolved towards gangrenous ulcers like
ecthyma gangrenosum. However, the right eye scotoma
still persisted. Finally, the patient was discharged from
hospital on day 24.sa. 1A. Erythematous nodules of the left side of the pelvis. 1B.
osis (arrows) and air-bronchogram of the left upper lobe. 1C.
is.
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an immunosuppressive status, including HIV testing, neu-
trophils count and functional activity, serum protein elec-
trophoresis, and biological dysimmunity. The results of
these tests were all negative, and there was no underlying
diabetes.Microbiological findings
The strain of P. aeruginosa (YIK) was investigated further.
This isolate turned out to belong to a quite rare sequence
type, ST137 (https://pubmlst.org/paeruginosa/), and like
the hypervirulent strain PA14,1 to code for an exotoxin
named ExoU. Considering the impressive ability of this
strain to invade multiple organs in an immunocompetent
individual, we examined the capacity of the strain to
induce epithelial cell death in vitro. The A549 cells were
incubated with YIK and laboratory strains PAO1 (thatFigure 2. P. aeruginosa YIK is cytotoxic on epithelial cells by usi
incorporation in A549 cells in presence of PAO1 (ExoSþ), PA14 (Exo
mean  SD of triplicates. Results are representatives of three indep
as area under curves (AUC). ANOVA, p < 0.001; Holm-Sidak’s post-ho
infected with YIK, in presence of either immune serum directed a
serum. At each time point, data represent mean  SD of quadrup
periments. 2D. Cytotoxicity curves in C. represented as area unde
*p Z 0.007, **p < 0.001. 2E. Detection of PcrV and ExoU. PAO1, PA
analysed by immunoblotting using specific antibodies raised agains
EGTA and MgCl2, as described in Materials and Methods.
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in presence of propidium iodide (PI) to monitor the kinetics
of membrane permeability over 300 min post-infection. The
cytotoxicity is presented as an increase in fluorescence
intensity (AU) and the calculated area under curve (AUC) as
described in the material and methods section. In accor-
dance with the fact that ExoSþ strains do not trigger ne-
crosis,2 PAO1 did not induce any significant incorporation of
PI within epithelial cells within time lapse of 300 min,
whereas YIK was the most cytotoxic strain (Fig. 2A and B),
causing even more cell death than the ExoU-positive strain
PA14. To assess whether the cytotoxicity induced by YIK
was dependent on an active type III secretion system
(T3SS), we used an immune serum directed against T3SS
protective antigen PcrV, which is an essential component of
this secretion machinery. This serum was previously shown
to inhibit P. aeruginosa induced haemolysis.3 Indeed, as
shown in Fig. 2C and D, the cytotoxicity of the YIK strain
towards A549 cells was significantly inhibited in theng the T3SS effector ExoU. 2A. Kinetic of propidium iodide (PI)
Uþ) or YIK, at a MOI of 10. At each time point, data represent
endent experiments. 2B. Cytotoxicity curves in A. represented
c test: **p < 0.001. 2C. Kinetic of PI incorporation in A549 cells
gainst the protective antigen PcrV (anti-PcrV) or non-immune
licates. Results are representatives of three independent ex-
r curves (AUC). ANOVA, p < 0.001; Holm-Sidak’s post-hoc test:
14 and YIK culture supernatants (S) or bacterial cells (B) were
t PcrV and ExoU. T3SS was induced where indicated by adding
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tion of cytotoxicity on A549 cell by the anti-PcrV serum
confirmed that the YIK induced cell death was caused by
the well-described T3SS effector ExoU.4 To confirm the
synthesis and secretion of ExoU by YIK, we performed
immunodetection of secreted proteins by different strains
under conditions where T3SS is induced by chelation of
calcium (þEGTA). ExoU was readily detected in whole
bacteria (B) and supernatants (S) of PA14 (positive control
strain) and YIK, and was absent from PAO1, that lacks gene
exoU. PcrV was detected in all three strains. In conclusion,
these experiments show that the YIK strain is highly cyto-
toxic on epithelial cells in an ExoU-dependent manner.
Materials and methods (online supplement)
Discussion
This observation is remarkable for several reasons. First,
the illness was community-acquired and occurred in a
subject with no known immunodeficiency. Second, the
illness was severe with septic shock and direct multiple
necrotizing organ damages (necrotizing pneumonia,
muscular abscesses, ecthyma gangrenosum, retinal
involvement and prostatic localisation). Third, an unusual
virulent strain of P. aeruginosa with ExoU positive pheno-
type was identified.
In a retrospective series of 39 cases of community-
acquired P. aeruginosa bacteraemia, Kang et al.5 reported
that the primary site of infection was the lung (23% of
cases), followed by the biliary (20%) and urinary (12%)
tracts. The initial presentation was associated with septic
shock in 38% of cases, overall mortality rate was 38.5% and
only 2 patients were immunocompetent. The overall inci-
dence of community-acquired P. aeruginosa bacteraemia is
estimated at 1 to 1.3/100,000,6 with a greater incidence in
men. The associated ocular damage due to P. aeruginosa is
also very atypical and few cases have been reported in
immunocompetent patients.7 In children, several severe
community-acquired cases of P. aeruginosa infection have
been reported in the context of Shanghai fever. Fever and
diarrhoea are the most common clinical presentation and
ecthyma gangrenosum occurs in more than 50% of cases.8 In
our case, there was no sign of enteritis, despite the fact
that the patient suffered initial digestive symptoms.
Virulence of P. aeruginosa is multifactorial.9,10 Among
the factors that P. aeruginosa may produce during infec-
tion, ExoU is of major clinical importance because of its
high cytotoxic and procoagulant activities, as well as its
role in vascular hyperpermeability, platelet activation and
thrombus formation.11 ExoU is a phospholipase directly
injected into the eukaryotic cells by the needle-like T3SS of
P. aeruginosa, with subsequent cell death and tissue ne-
crosis. Infections related to ExoU-producing strains are
associated with more severe clinical symptoms and poorer
outcomes, as compared with ExoS-positive (ExoU-negative)
isolates.11,12 They are also responsible for acute lung
epithelial injury, sepsis, and corneal lesions.13 In 328 P.
aeruginosa clinical and environmental isolates collected
worldwide, Pirnay J-P et al. reported that 73% of isolates
harboured the exoS gene, which was indicative of anPlease cite this article as: Elabbadi A et al., An unusual community-acq
Pseudomonas aeruginosa strain: Clinical disease and microbiological c
https://doi.org/10.1016/j.jmii.2019.06.008invasive phenotype, and that 23% of isolates harboured the
exoU gene, which was associated with virulence and dis-
ease severity.14 There was no difference in the distribution
of genotypes between clinical and environmental isolates,
except for the cystic fibrosis (CF) isolates that exhibited
almost exclusively the exoSþ/exoU- genotype, which might
be required for the process of a bronchial colonization in CF
lungs. The examination of the Shanghai fever strains
showed that 59% of them were carrying an ExoU strain, and
41% an ExoS strain. Shanghai fever isolates with exoU were
significantly more cytotoxic than isolates with exoS.8
Innovative therapeutic strategies, based on T3SS-
targeting antibodies or inhibitors, have been proposed
over the last decade to combat nosocomial strains of P.
aeruginosa.11,15 As illustrated here, such novel approaches
could also be valuable in the treatment of life-threatening
community-acquired infections.Conclusion
We report a rare case of a particularly severe lower respi-
ratory tract infection with septic shock and multiple direct
necrotizing organ damages due to a highly cytotoxic strain
of P. aeruginosa exhibiting an ExoU-phenotype. Physicians
should be aware of the possible occurrence of such an
infection in immunocompetent hosts, to early target anti-
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